Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
OC(=O)CC1=CC(=CC=C1)OCCCN(CC(C1C=CC=CC=1)C1C=CC=CC=1)CC1=CC=CC(=C1Cl)C(F)(F)F
InChiKey: WINHZLLDWRZWRT-ATVHPVEESA-N
13(12):2055-8
indicating that the dependence on oleate is inherent to the pluripotent cells
InChi: InChI=1S/C17H13N5/c1-11-4-2-5-16(20-11)17-12(10-19-22-17)13-7-8-14-15(21-13)6-3-9-18-14/h2-10H
NS-304 Size:Solid 2 mg OC(=O)CC1=CC(=CC=C1)OCCCN(CC(C1C=CC=CC=1)C1C=CC=CC=1)CC1=CC=CC(=C1Cl)C(F)(F)FSelexipag, also known as ACT 293987 and NS 304, is a a first in class orally available selective non prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT 333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. Product information CAS Number: 475086 01 2 Molecular Weight: 496. 62
US$ 40.00
US$ 25.00
US$ 40.00
US$ 80.00
US$ 308.00
US$ 30.00